title: Day-case transfer for percutaneous coronary intervention with adjunctive abciximab in acute coronary syndromes.
authors.forename: D J
authors.initials: DJ
authors.lastname: Blackman
authors.forename: N R
authors.initials: NR
authors.lastname: Clarke
authors.forename: W P
authors.initials: WP
authors.lastname: Orr
authors.forename: E
authors.initials: E
authors.lastname: Wilkinson
authors.forename: A
authors.initials: A
authors.lastname: Beswick
authors.forename: D
authors.initials: D
authors.lastname: Coppock
authors.forename: D C
authors.initials: DC
authors.lastname: Sprigings
authors.forename: A P
authors.initials: AP
authors.lastname: Banning
mesh_terms: D000077284:Abciximab; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D003631:Day Care, Medical; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010360:Patient Transfer; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012017:Referral and Consultation
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab